SEC 13F Intelligence

Managers / Q1 2022 · view latest →

Ayrton Capital LLC

CIK 0001698148 · 55 POST RD WEST, 2ND FLOOR, WESTPORT, CT, 06880 · 646-793-9056

Reported Value
$77M
Q1 2022
Positions
123
Filings on Record
8
2019–present window
Filed
May 12, 2022
original filing

Summary

Ayrton Capital LLC reported $77M in U.S.-listed holdings across 123 positions for Q1 2022.

Its largest position, Neurocrine Biosciences, represents 6.8% of the portfolio.

Compared with Q4 2021, the fund opened 35 new positions and exited 30.

Portfolio Metrics

Turnover
+33.2%
vs prior filed quarter
Top-10 Concentration
+40.6%
share of reported value
Largest Position
+6.8%
Neurocrine Biosciences
New / Exited
35 / 30
positions this quarter

Methodology: turnover is min(value bought, value sold) ÷ average reported value across the two quarters — value-based, so market moves inflate it slightly versus a share-based measure. Concentration and largest position are shares of the filing’s total reported value, options excluded. New/exited counts compare against the prior filed quarter. All figures derive solely from the fund’s 13F filings.

Reported Value by Quarter

13F Reported Value
Q4 ’21: $106MQ4 ’21Q1 ’22: $77MQ1 ’22Q2 ’22: $62MQ2 ’22Q3 ’22: $57MQ3 ’22Q4 ’22: $37MQ4 ’22Q1 ’23: $28MQ1 ’23Q2 ’23: $16MQ2 ’23Q3 ’23: $15MQ3 ’23filingsflow.com

Portfolio Composition

By security type
Other: 57.2%US DOMESTIC: 39.4%Common Stock: 3.0%Equity WRT: 0.4%
  • Other · 57.2% · $44M
  • US DOMESTIC · 39.4% · $30M
  • Common Stock · 3.0% · $2M
  • Equity WRT · 0.4% · $303,000

Quarter-over-Quarter Changes full breakdown →

vs Q4 2021 (amended baseline)

IssuerMoveShare ΔShares nowValue ΔValue now
MANNKIND CORPNEW+4.75M4.75M+$5M$5M
INDUSTRIAL HUMAN CAPITAL INCNEW+250.0K250.0K+$3M$3M
RELATIVITY ACQUISITION CORPNEW+200.0K200.0K+$2M$2M
DIGITAL HEALTH ACQUISITION CNEW+200.0K200.0K+$2M$2M
LIBERTY RES ACQUISITION CORPNEW+175.0K175.0K+$2M$2M
FIVE9 INCNEW+1.50M1.50M+$2M$2M
NOVOCURE LTDNEW+1.50M1.50M+$1M$1M
ALARM COM HLDGS INCNEW+1.50M1.50M+$1M$1M

Value changes conflate price moves with buying and selling — share changes are the real signal. Share counts are not split-adjusted.

Holdings — Q1 2022

50 positions
Export to Excel
#IssuerClass% PortfolioValue ↓Shares
1NEUROCRINE BIOSCIENCES INCNOTE 2.250% 5/16.84%$5M4.00M
2MANNKIND CORPNOTE 2.500% 3/06.19%$5M4.75M
3ATLAS AIR WORLDWIDE HLDGS INNOTE 1.875% 6/05.86%$5M3.00M
4ENVESTNET INCNOTE 1.750% 6/04.70%$4M3.00M
5LMF ACQUISITION OPPORTUNIT ICL A COM3.29%$3M250.0K
6INDUSTRIAL HUMAN CAPITAL INCCOM3.26%$3M250.0K
7OTR ACQUISITION CORPCOM CL A2.65%$2M200.0K
8RELATIVITY ACQUISITION CORPUNIT 02/10/20272.62%$2M200.0K
9DIGITAL HEALTH ACQUISITION CCOMMON STOCK2.60%$2M200.0K
10SUPERNUS PHARMACEUTICALSNOTE 0.625% 4/02.57%$2M2.00M
11PROS HOLDINGS INCNOTE 1.000% 5/12.44%$2M2.00M
12AFRICAN GOLD ACQUISITION CORSHS CL A2.32%$2M182.1K
13MODEL PERFORMANCE ACQU CORPCLASS A ORD SHS2.30%$2M175.0K
14LIBERTY RES ACQUISITION CORPCLASS A COM2.27%$2M175.0K
15SABRE GLBL INCNOTE 4.000% 4/12.15%$2M1.00M
16FIVE9 INCNOTE 0.500% 6/02.12%$2M1.50M
17VISION SENSING ACQUISITION CCLASS A COM1.95%$1M150.0K
18GIGINTERNATIONAL1 INCCOM1.94%$1M149.6K
19AGBA ACQUISITION LTDSHS1.81%$1M125.0K
20NOVOCURE LTDNOTE 11/01.78%$1M1.50M
21GOLDENBRIDGE ACQUISITION LTDSHS1.75%$1M134.5K
22ALARM COM HLDGS INCNOTE 1/11.66%$1M1.50M
23OCEANTECH ACQUISITIONS I CORCLASS A COM1.64%$1M125.0K
24AROGO CAPITAL ACQUISITION COCLASS A COM1.62%$1M125.0K
25FINTECH ECOSYSTEM DEVECLASS A COM1.62%$1M125.0K
261847 GOEDEKER INC*W EXP 99/99/9991.61%$1M2.00M
27LIVEPERSON INCNOTE 12/11.54%$1M1.50M
28AIR TRANS SVCS GROUP INCNOTE 1.125%10/11.54%$1M1.00M
29ALSET CAPITAL ACQUISITION COUNIT 01/31/20271.31%$1M100.0K
30GSR II METEORA ACQUISITN CORUNIT 02/24/20271.31%$1M100.0K
31WESTERN ACQSTN VENTURES CORPUNIT 09/01/20261.30%$1M100.0K
32KHOSLA VENTURES ACQUISITIONCL A1.29%$995,000101.7K
33FINNOVATE ACQUISITION CORPCLASS A ORD SHS1.29%$991,000100.0K
34ADARA ACQUISITION CORPCOM CL A1.28%$983,00099.5K
35MMTEC INCSHS1.18%$908,0001.48M
36ANZU SPECIAL ACQUISITIN CORPCOM CL A1.05%$810,00082.9K
37KAIROUS ACQUISITION CORP LTDORDINARY SHARES0.97%$744,00075.0K
38MEDICUS SCIENCES ACQUISITIONCL A SHS0.95%$730,00074.6K
39BLUE SAFARI GRP ACQUISITN COCLASS A ORD SHS0.91%$704,00070.0K
40MINORITY EQUALITY OPPORTUNITCLASS A COM0.91%$703,00070.0K
41WARRIOR TECHNOLOGIES ACQUI CCOM CL A0.85%$651,00065.8K
42OXUS ACQUISITION CORPSHS CL A0.79%$610,00060.0K
43FLAME ACQUISITION CORPCOM CL A0.71%$545,00055.9K
44AGRICO ACQUISITION CORPCLASS A ORD SHS0.66%$506,00050.0K
45CONCORD ACQUISITION CORP IIICOM CL A0.65%$497,00050.0K
46CHAVANT CAPITAL ACQUISITN COORDINARY SHARES0.64%$496,00050.0K
47EJF ACQUISITION CORPCL A SHS0.64%$495,00050.0K
48NORWEGIAN CRUISE LINE HLDG LSHS0.56%$432,00019.7K
49RECHARGE ACQUISITION CORPCOM CL A0.54%$419,00042.0K
50BRTXBIORESTORATIVE THERAPIES INCCOM NEW0.53%$407,00077.8K

Filing History

QuarterReported ValuePositionsFiledTypeLinks
Q3 2023$15M71Nov 13, 202313F-HRchanges · EDGAR ↗
Q2 2023$16M74Aug 14, 202313F-HRchanges · EDGAR ↗
Q1 2023$28M85May 12, 202313F-HRchanges · EDGAR ↗
Q4 2022$37M95Feb 14, 202313F-HRchanges · EDGAR ↗
Q3 2022$57M118Nov 9, 202213F-HRchanges · EDGAR ↗
Q2 2022$62M120Aug 15, 202213F-HRchanges · EDGAR ↗
Q1 2022$77M123May 12, 202213F-HRchanges · EDGAR ↗
Q4 2021$106M118Feb 11, 202213F-HRchanges · EDGAR ↗

13F filings are due up to 45 days after quarter end, so holdings shown here lag the fund’s current book. Source: original SEC filing on EDGAR ↗.